BD Primary Care Point-of-Care Immunoassay Analyzer BD Veritor™ Plus CLIA Waived - M-1029527-4811 - Each

Packaging *

BD Primary Care

Point-of-Care Immunoassay Analyzer

In Stock

M-1029527-4811

-
+

Item is Non - Returnable

Delivery - 7-10 Days, Ship Directly from Manufacturer

  • CLIA-waived digital immunoassay for rapid detection of SARS-CoV-2, Flu A+B, RSV and Group A Strep
  • Advanced particle technology enhances sensitivity by using a proprietary process to produce highly stable, modifi ed colloidal metal particles, helping improve test performance
  • Adaptive read technology helps improve specificity to reduce false-positive results by compensating for background and non-specific binding
  • Fast and accurate assay performance
  • Prefilled color-coded unitized tubes by reagent facilitate workflow
  • Swab or liquid sample is inserted into unitized tube, processed and removed
  • Test device may be inserted immediately into Analyzer (Walk Away mode) or after incubation time is complete (Analyze Now mode)
  • Print-enabled through USB
  • Good for 10,000 tests or 24 months without maintenance or calibration

  • Item Id 1029527
    MF ID 256066
    Brand BD Veritor™ Plus
    Manufacturer BD Primary Care
    Application Point-of-Care Immunoassay Analyzer
    CLIA Classification CLIA Waived
    Contents1 BD Veritor Plus Analyzer, Instructions for Use Manual, USB Port Unlock Barcode Label, AC Power Adapter, BD Verification Cartridge
    Dimensions 7.6 X 9 X 14.3 cm
    For Use With For BD Veritor™ System Test Devices
    Power Source 100 to 240 VAC at 50 to 60 Hz, 0.6A
    Readout Type Digital Readout, Printout (Option)
    Sample Type Throat Swab / Nasal Swab / Nasopharyngeal Swab / Nasopharyngeal Aspirate or Wash Sample
    Test Name Influenza A + B, Respiratory Syncytial Virus (RSV), and Group A Strep
    Time To Results 5 Minute Results
    UNSPSC Code 41116144
    User Interface LCD Display
    Weight 300 g

    Have Questions? Ask An Expert

    Recently Viewed Products